[Integrated Care Protocol: Prevention, diagnosis and treatment of diabetes mellitus 2].
| Autor: | Medina-Chávez JH; Instituto Mexicano del Seguro Social, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México., Vázquez-Parrodi M; Instituto Mexicano del Seguro Social, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México., Mendoza-Martínez P; Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades 'Dr. Antonio Fraga Mouret', Servicio de Endocrinología. Ciudad de México, México., Ríos-Mejía ED; Instituto Mexicano del Seguro Social, Hospital General de Zona No. 2, Servicio de Medicina Interna. Aguascalientes, Aguascalientes, México., de Anda-Garay JC; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Servicio de Medicina Interna. Ciudad de México, México., Balandrán-Duarte DA; Instituto Mexicano del Seguro Social, Coordinación de Innovación en Salud, División de Excelencia Clínica. Ciudad de México, México. |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2022 Feb 07; Vol. 60 (Supl 1), pp. S4-S18. Date of Electronic Publication: 2022 Feb 07. |
| Abstrakt: | Background: Type 2 diabetes mellitus (DM2) represents one of the ten non- transmissible chronic diseases that constitute the main causes of death and disability in Mexico. It is the leading cause of disability and the second cause of death. The IMSS serves 4.2 million people living with this disease. Objective: Establish lines of action that allow standardizing the substantive activities to be carried out by the multidisciplinary health team, promoting healthy lifestyles, establishing timely diagnoses, providing adequate and intensified care and treatments, preventing complications, and providing comprehensive care and of quality for the benefit of the beneficiaries. Material and Methods: The process of development of the Integrated Care Protocols consisted of: 1) Prioritization of the health problem, 2) Conformation of an interdisciplinary work group, 3) Development of content and systematic search for information 4) Analysis, review and discussion of interventions, 5) Review and validation by regulatory areas, 6) Dissemination and implementation. Conclusions: Promotion and prevention actions must be carried out at all levels and by all health personnel, likewise, the incorporation of new treatments for DM2 in the IMSS, requires the homologation of the criteria in risk stratification, diagnosis, profile risk of hypoglycemia and adverse effects to limit the complications of the disease and reduce the burden of disease (disability and premature death). (© 2022 Revista Medica del Instituto Mexicano del Seguro Social.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|